Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Jenkins

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|November 15, 2003
Prospects for biodiversityMartin Jenkins
Pharmaceutical Statistics|February 14, 2012
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpointsMartin Jenkins, Andrew Stone, Christopher Jennison
Rheumatology (Oxford, England)|June 25, 2016
Improving the power of clinical trials of rheumatoid arthritis by using data on continuous scales when analysing response rates: an application of the augmented binary methodJames M S Wason, Martin Jenkins
Nurse Education Today|November 6, 2021
Defining 'research inspired teaching' and introducing a research inspired online/offline teaching (riot) framework for fostering it using a co-creation approachSally Pezaro, Martin Jenkins, Martin Bollard
Respiratory Medicine|December 27, 2011
AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPDPiotr Kuna, Martin Jenkins, Christopher D O'Brien, et al.
Therapeutic Advances in Respiratory Disease|July 11, 2022
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flowBärbel Huber, Claus Keller, Martin Jenkins, et al.
BMC Medical Research Methodology|May 25, 2022
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS studyKirsty Rhodes, Martin Jenkins, Enrico de Nigris, et al.
Respiratory Medicine|November 14, 2025
Frequent productive cough in COPD relates to exacerbation risk and treatment benefit from budesonide/glycopyrrolate/formoterol fumarate: a post hoc analysis of KRONOSMehul Patel, Jonathan Marshall, Fernando J Martinez, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 11, 2024
Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trialDan Jackson, Martin Jenkins, Enrico de Nigris, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 27, 2021
Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the EvidenceOmar S Usmani, Nicolas Roche, Martin Jenkins, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|November 15, 2003
Prospects for biodiversityMartin Jenkins
Pharmaceutical Statistics|February 14, 2012
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpointsMartin Jenkins, Andrew Stone, Christopher Jennison
Rheumatology (Oxford, England)|June 25, 2016
Improving the power of clinical trials of rheumatoid arthritis by using data on continuous scales when analysing response rates: an application of the augmented binary methodJames M S Wason, Martin Jenkins
Nurse Education Today|November 6, 2021
Defining 'research inspired teaching' and introducing a research inspired online/offline teaching (riot) framework for fostering it using a co-creation approachSally Pezaro, Martin Jenkins, Martin Bollard
Respiratory Medicine|December 27, 2011
AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPDPiotr Kuna, Martin Jenkins, Christopher D O'Brien, et al.
Therapeutic Advances in Respiratory Disease|July 11, 2022
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flowBärbel Huber, Claus Keller, Martin Jenkins, et al.
BMC Medical Research Methodology|May 25, 2022
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS studyKirsty Rhodes, Martin Jenkins, Enrico de Nigris, et al.
Respiratory Medicine|November 14, 2025
Frequent productive cough in COPD relates to exacerbation risk and treatment benefit from budesonide/glycopyrrolate/formoterol fumarate: a post hoc analysis of KRONOSMehul Patel, Jonathan Marshall, Fernando J Martinez, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 11, 2024
Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trialDan Jackson, Martin Jenkins, Enrico de Nigris, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 27, 2021
Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the EvidenceOmar S Usmani, Nicolas Roche, Martin Jenkins, et al.
Pageof 4